当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 资产负债表

振东制药

(300158)

  

流通市值:49.26亿  总市值:49.42亿
流通股本:10.24亿   总股本:10.27亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金974,682,707.26885,235,637.16769,051,793.53720,266,919.95
应收票据及应收账款778,480,043.66795,014,217.89855,248,673.63809,300,617.82
其中:应收票据132,583,041.68157,128,014.19152,507,800.41104,076,437.8
应收账款645,897,001.98637,886,203.7702,740,873.22705,224,180.02
预付款项148,450,784.04138,206,913.53111,013,500.64187,223,928.9
其他应收款合计54,532,030.1648,809,724.6589,642,443.9557,441,405.88
存货1,214,275,309.911,134,495,091.751,279,968,680.021,074,458,576.25
其他流动资产8,267,850.939,697,823.3511,986,937.5715,306,474.02
流动资产平衡项目0000
流动资产合计4,496,055,422.94,556,663,145.364,761,788,6794,883,273,988.04
非流动资产:
长期应收款--116,130.4116,130.4
其他权益工具投资36,943,869.3636,943,869.3668,341,497.7858,341,497.78
投资性房地产15,851,854.516,053,361.12--
固定资产928,744,616.67941,891,538.14960,928,699.29983,694,390.85
在建工程47,437,701.2235,837,040.429,692,483.1524,210,450.69
生产性生物资产1,069,501.711,069,501.711,110,636.391,151,771.07
使用权资产2,596,040.032,835,856.442,538,385.751,163,063.49
无形资产255,864,594.41255,872,614.49260,011,772.65258,389,902.2
开发支出200,825,198.94198,197,723.14195,832,937.36192,786,741.19
商誉40,239,614.1840,239,614.1840,239,614.1840,239,614.18
长期待摊费用5,222,827.696,841,955.839,160,909.748,270,394.01
递延所得税资产19,810,530.3519,987,051.1618,511,340.818,870,064.77
其他非流动资产90,083,06888,566,540.7382,855,917.680,406,903.48
非流动资产平衡项目0000
非流动资产合计1,644,689,417.061,644,336,666.71,669,340,325.091,667,640,924.11
资产平衡项目0000
资产总计6,140,744,839.966,200,999,812.066,431,129,004.096,550,914,912.15
流动负债:
短期借款--20,016,666.6720,478,590.19
应付票据及应付账款450,754,472.14491,075,655.69561,795,461.7504,484,948.63
其中:应付票据36,522,463.3837,741,033.6638,322,158.4734,177,928
应付账款414,232,008.76453,334,622.03523,473,303.23470,307,020.63
合同负债61,921,937.4686,760,752.8488,021,651.25147,587,680.36
应付职工薪酬27,249,889.7921,712,444.8325,632,671.9428,907,251.56
应交税费37,435,853.4545,905,593.237,432,033.6355,417,992.83
其他应付款合计242,734,786.28215,289,789.38341,308,022.78433,462,862.8
一年内到期的非流动负债806,573.39806,573.39314,323.14314,323.14
其他流动负债15,630,577.9417,068,575.515,260,462.2218,679,422.16
流动负债平衡项目0000
流动负债合计836,534,090.45878,619,384.831,089,781,293.331,209,333,071.67
非流动负债:
租赁负债1,916,656.271,880,481.431,761,159.611,080,908.22
长期应付款74,905,173.0375,915,173.0374,715,173.0374,715,173.03
递延收益39,575,033.6640,420,402.1942,472,078.0742,494,977.82
非流动负债平衡项目0000
非流动负债合计116,396,862.96118,216,056.65118,948,410.71118,291,059.07
负债平衡项目0000
负债合计952,930,953.41996,835,441.481,208,729,704.041,327,624,130.74
所有者权益(或股东权益):
实收资本(或股本)1,027,494,6601,027,494,6601,027,494,6601,027,494,660
资本公积3,762,314,237.723,762,314,237.723,762,314,237.723,762,314,237.72
其他综合收益-32,737,641.89-32,730,551.68-1,384,236.06-1,394,820.6
盈余公积481,346,118.6481,346,118.6481,346,118.6481,346,118.6
未分配利润-16,480,436.54-1,063,821.26-16,000,960.16-15,606,231.63
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,221,936,937.895,237,360,643.385,253,769,820.15,254,153,964.09
少数股东权益-34,123,051.34-33,196,272.8-31,370,520.05-30,863,182.68
股东权益平衡项目0000
股东权益合计5,187,813,886.555,204,164,370.585,222,399,300.055,223,290,781.41
负债和股东权益合计6,140,744,839.966,200,999,812.066,431,129,004.096,550,914,912.15
公告日期2023-10-232023-08-312023-04-252023-04-25
审计意见(境内)标准无保留意见
TOP↑